Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 16 , ISSUE 4 ( July-August, 2024 ) > List of Articles

Original Article

Effect of Hemoglobinopathy on Maternal and Fetal Outcome: Single Center Study

Jigna P Patel, Rushika N Parikh, Rutik Thorat

Keywords : Hemoglobinopathic pregnancies, Maternal outcomes, Neonatal outcomes

Citation Information : Patel JP, Parikh RN, Thorat R. Effect of Hemoglobinopathy on Maternal and Fetal Outcome: Single Center Study. J South Asian Feder Obs Gynae 2024; 16 (4):402-405.

DOI: 10.5005/jp-journals-10006-2452

License: CC BY-NC 4.0

Published Online: 09-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background and aim: Hemoglobinopathies pose to be a major risk factor for pregnancy leading to potentially fatal maternal and neonatal complications. The aim of our study was to compare maternal and neonatal outcomes of pregnancy in women with a hemoglobinopathy and without a hemoglobinopathy. Materials and methods: The present study is a comparative retrospective analysis of 153 pregnant women with hemoglobinopathies and 153 pregnant women without hemoglobinopathies who were treated between June 2020 and May 2023, in Dhiraj Hospital, Vadodara. We analyzed various data regarding maternal as well as neonatal outcomes and complications in hemoglobinopathies. Results: Among the maternal outcomes, the rate of previous miscarriage, intrauterine growth restriction (IUGR), postpartum hemorrhage (PPH), and anemia were significantly increased in women with hemoglobinopathies. Among the neonatal outcomes, the rate of anemia and low birth weight were significantly increased in all type of hemoglobinopathic pregnancies. Hepatic encephalopathy, septicemia, jaundice, perinatal death, and fetal acidosis were also increased in sickle cell disease (SCD) pregnancies. Conclusion: It is pivotal to supervise pregnancies with hemoglobinopathies for minimal morbidity and mortality in mother as well as fetus. Timely multispecialty intervention can help in improving the fetomaternal outcomes.

HTML PDF Share
  1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480–487. DOI: 10.2471/blt.06.036673.
  2. Chauhan A, Prasad M. Outcome of pregnancy with hemoglobinopathy in a tertiary care center. J Obstet Gynaecol India 2018;68(5):394–399. DOI: 10.1007/s13224-017-1073-5.
  3. Piel FB, Hay SI, Gupta S, et al. Global burden of sickle cell anaemia in children under five, 2010-2050: Modelling based on demographics, excess mortality, and interventions. PLoS Med 2013;10(7):e1001484. DOI: 10.1371/journal.pmed.1001484.
  4. Hockham C, Bhatt S, Colah R, et al. The spatial epidemiology of sickle-cell anaemia in India. Sci Rep 2018;8(1):17685. DOI: 10.1038/s41598- 018-36077-w.
  5. Aliyeva G, Asadov C, Mammadova T, et al. Thalassemia in the laboratory: Pearls, pitfalls, and promises. Clin Chem Lab Med 2018;57(2):165–174. DOI: 10.1515/cclm-2018-0647.
  6. Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfusion Sci 2016;10(1):105–110. DOI: 10.4103/0973-6247.175424.
  7. Government of India. Prevention and Control of Haemoglobinopathies in India: Thalassaemias, Sickle Cell Disease and other Variant Haemoglobins (National Health Mission Guidelines on Hemoglobinopathies in India). New Delhi: Ministry of Health & Family Welfare; 2016a. DOI: 10.19070/2379-1586-150008.
  8. Charoenboon C, Jatavan P, Traisrisilp K, et al. Pregnancy out-comes among women with beta-thalassemia trait. Arch Gynecol Obstet 2016;293(4):771–774. DOI: 10.1007/s00404-015-3908-6.
  9. Anderson GW, Busby T. Sickle cell anemia and pregnancy. Am j Obstet Gynecol 1949; 58(1):75–89. DOI: 10.1016/0002-9378(49)90008-3.
  10. Tuck SM. Studd JWW, White JM. Pregnancy in women with sickle cell trait. Br J Obstet Gynaecol 1983;90(2):108–111. DOI: 10.1111/j.1471-0528.1983.tb08892.x.
  11. Sonwane A. Pregnancy outcome in women with sickle cell disease and trait. J Obstet Gynecol 2005;55(5):415–418.
  12. Daigavane MM, Jena RK, Kar TJ. Perinatal outcome in sickle cell anemia: A prospective study from India. Randomized Controlled Trial, Hemoglobin 2013;37(6):507–515. DOI: 10.3109/03630269.2013. 828301.
  13. Cardoso PSR, de Aquiar RALP, Vianaa MB. Clinicalcomplications in pregnant women with sickle cell disease: Prospective study of factors predicting maternal death or near miss. Rev Bras Hematol Hemoter 2014;36(4):256–263. DOI: 10.1016/j.bjhh.2014.05.007.
  14. Mc Curdy PR. Abnormal haemoglobin and pregnancy. Am J Obstet Gynecol 1964;90(7):891–896. DOI: 10.1016/0002-9378(64)90783-5.
  15. Oteng-Ntim E, Meeks D, Seed PT, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: Systematic review and meta-analysis. Blood 2015b;125(21):3316–3325. DOI: 10.1182/blood-2014-11-607317.
  16. Al Kahtani MA, AlQatani M, Alshebaily MM, et al. Morbidity and pregnancy outcomes associated with sickle cell anemia among Saudi women. Int J Gynaecol Obstet 2012;119(3):224–226. DOI: 10.1016/j.ijgo.2012.07.008.
  17. Alayed N, Kezouh A, Oddy L, et al. Sickle cell disease and pregnancy outcomes: Population-based study on 8.8 million births. J Perinat Med 2014;42(4):487–492. DOI: 10.1515/jpm-2013-0275.
  18. Al Kobak AJ, Stein PJ, Daro AF. Sickle-cell anemia in pregnancy: A review of the literature and report of six cases. Am J Obstet Gynecol 1941;41(5):811–823. DOI: 10.1016/S0002-9378(41)90869-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.